Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Some medications can cause acne, and stopping these drugs is the main treatment.

Some drugs used to treat inflammation may cause hair loss.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Current research explores hair growth drugs, while future research aims for personalized treatments.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Avoiding certain nutrients and drugs may help manage pemphigus.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.